Place of the “Public health” in the Tunisian medical research on the cardiovascular diseases: a bibliometric study (Medline: 1988-2017)

##plugins.themes.academic_pro.article.main##

Hichem DENGUIR
Asma Ben Abdelaziz
Khaled OUELD BEYA
Anhar KAABIA
Oussama BOUABDELLAH
Dina BEN MOHAMMED
Ahmed Ben Abdelaziz

Abstract

Background:  The management of the cardiovascular diseases, main public health problem in Tunisia, is generating many difficulties that a socially responsible research should reflect them. The aim of this study is to assess dimensions of public health of Tunisian research on the cardiovascular diseases during thirty last years.
Methods: we conducted a bibliometric study relating to the public health information of the Tunisian cardiovascular papers indexed in the Medline database between January 1st 1988 and December 31st 2017. The following qualifiers were selected to define the public health dimension of paper: “epidemiology”, “mortality”, “statistics and numerical data”, “economy”, and “prevention and control”.
Results: During thirty years (1988-2017), 176 citationsRaws were identified and only 136 Tunisian publications were retained following the application of the inclusion criteria (first author affiliated in a Tunisian structure of health or research). The two medical specialties of “cardiology” and “Preventive medicine and Community” produced 47% of these articles. The selected publications were mainly original articles, monocentric studies, analytical, and written in French language for the national journal “La Tunisie Medicale”. Among the 136 selected articles, 34 (25%) explored the ischemic heart diseases. “Epidemiology” and the “Prevention/Control” were two dimensions of the “Public health” the most studied in the Tunisian publications on the cardiovascular diseases, respectively in 84% and 44% of the cases.
Conclusion: The Tunisian publications in the cardiovascular field accompanied the epidemiologic transition along the three last decades. While they were focusing on the epidemiology and the prevention of the ischemic heart diseases. Other dimensions of public health must be treated on the set of the cardiovascular diseases, such as the economics and etiologics studies.

Keywords:

Cardiovascular Diseases - Public Health - Bibliometric - Medline - Tunisia

##plugins.themes.academic_pro.article.details##

References

  1. Mokdad AH, Forouzanfar MH, Daoud F et al Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Glob Health. 2016 Oct;4(10):e704-13.
  2. Critchley J, Capewell S, O'Flaherty M et al Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: Contributions from risk factor changes and treatments. Int J Cardiol. 2016 Apr 1;208:150-61.
  3. Huffman MD, Baldridge A, Bloomfield GS, Colantonio LD, Prabhakaran P, Ajay VS, Suh S, Lewison G, Prabhakaran D. Global cardiovascular research output, citations, and collaborations: a time-trend, bibliometric analysis (1999-2008). PLoS ONE. 2013;8:e83440.
  4. Gerald S. Bloomfield, Abigail Baldridge, Anubha Agarwal, et al Disparities in Cardiovascular Research Output and Citations From 52 African Countries: A Time-Trend, Bibliometric Analysis (1999-2008) J Am Heart Assoc. 2015;4:e001606
  5. Ben Youssef S, Guermazi N, Khrouf B, Grati S, Daoud M. Clinical course and prognosis of myocardial infarction Tunis Med. 1993 Nov; 71(11):497-503.
  6. Mghaieth F, Aloui H, Chabrak S et al. inhospital prognosis of acute myocardial infarction: comparison of two periods to ten years of interval Ann Cardiol Angeiol (Paris). 2006 Oct;55(5):241-5.
  7. Ben Romdhane H, Bougatef S, Skhiri H, et al The first Tunisian cardiovascular diseases register: processes and results Rev Epidemiol Sante Publique. 2004 Dec;52(6):558-64.
  8. Bougatef S, Ben Romdhane H, Haouala H et al Knowledge, treatment and control of hypertension. Results of a multicenter study of patients hospitalized for cardiac ischemia Tunis Med. 2002 Jul;80(7):387-94.
  9. Jemaa R, Kafsi MN, Kallel A et al Distribution of cardiovascular risk factors in a Tunisian cohort of 6901 coronary patients Arch Mal Coeur Vaiss. 2004 Jan;97(1):20-4.
  10. Baccouche H, Belguith AS, Boubaker H et al Acute coronary syndrome among patients with chest pain: Prevalence, incidence and risk factors Int J Cardiol. 2016 Jul 1;214:531-5.
  11. Ben Ahmed H, Boussaid H, Hamdi I, Longo S, Baccar H5, Boujnah MR. Diagnostic accuracy of Epworth sleepiness scale in the acute phase of myocardial infarction Rev Pneumol Clin. 2014 Jun;70(3):142-7.
  12. Addad F, Dridi Z, Jemmali M et al Smoker's paradox" and reperfusion's strategy in acute myocardial infarction Ann Cardiol Angeiol (Paris). 2010 Aug;59(4):183-9
  13. Kraiem S, Abassi C, Annabi N et al Screening and management of coronary artery disease in diabetic patients Tunis Med. 2006 Oct;84(10):670-6.
  14. Lihioui M1, Boughzala E, Ben Farhat M [Distribution of cardiovascular risk factors in coronary patients in Sahel, Tunisia]. East Mediterr Health J. 2007 May-Jun;13(3):536-43.
  15. Jomaa W, Hamdi S, Ben Ali I, Risk profile and in-hospital prognosis in elderly patients presenting for acute ST-elevation myocardial infarction in the Tunisian context. Indian Heart J. 2016 Nov - Dec;68(6):760-765.
  16. Hajlaoui N, Ellefi H, Jdaida B, et al [Acute myocardial infarction in elderly patients].Tunis Med. 2012 Jul;90(7):542-7.
  17. Allal-El Asmi M, Mebazaa A, Zidi W et al. Psoriasis is associated with increased Framingham ten-year risk score for coronary heart disease in Tunisians. Clin Lab. 2013;59(11-12):1247-52.
  18. Kraiem S, Baraket F, Longo S et al Predictive factors of significant coronary stenosis in women. Review of 230 patients Tunis Med. 2006 Sep; 84(9):545-51.
  19. Larbi N, Lakhdar R, Chabrak S, Kafsi MN. Prognosis of intraventricular septal rupture in myocardial infarct: apropos of 13 cases Tunis Med. 1999 Oct;77(10):515-9.
  20. Baffoun N, Lakhdhar R, Baccar K, Djebari K, Kaddour C. Cardiac injury in traumatic subarachnoid hemorrhagea: prospective study in 35 patients. Tunis Med. 2011 Feb;89(2):184-7.
  21. Saidi O, Ben Mansour N, O'Flaherty M, Capewell S, Critchley JA, Ben Romdhane H Analyzing recent coronary heart disease mortality trends in Tunisia between 1997 and 2009. PLoS One. 2013 May 3;8(5):e63202.
  22. Abdessalem S, Mjadlah S, Mahjoub H, Mourali S, Mechemeche R. Immediate and 12-month outcomes of an interventional reperfusion strategy in acute ST elevation myocardial infarction. Report of 208 successive patients Tunis Med. 2009 Nov;87(11):755-62.
  23. Ben Ahmed H1, Allouche M, Zoghlami B et al Diurnal, weekly and seasonal variation of sudden cardiac death in northern Tunisia Presse Med. 2014 Apr;43(4 Pt 1): e39-45.
  24. Bouraoui H, Trimeche B, Ernez-Hajri S et al Impact of diabetes on mortality after myocardial infarction Ann Cardiol Angeiol (Paris). 2005 Mar;54(2):55-9.
  25. Jerbi B, Sahnoun M, Abid L et al Chronic kidney disease and myocardial infarction: epidemiological, clinical, therapeutic and prognostic characteristics (about 231 cases)]. Ann Cardiol Angeiol (Paris). 2011 Jun;60(3):127-34.
  26. Bezdah L, Malou M, Akram Drissa M et al In-hospital prognosis of right ventricular myocardial infarction Tunis Med. 2007 Sep;85(9):788-92.
  27. Ghodbane W, Ragmoun W, Arbi R et al Correlation between previous coronary artery stenting and early mortality in patients undergoing coronary artery bypass graft surgery Ann Cardiol Angeiol (Paris). 2013 Dec;62(6):429-34
  28. Ben Romdhane H, Bougatef S, Skhiri H, Gharbi D, Haouala H, Achour N Population surveillance of coronary heart disease Tunis Med. 2005 May;83 Suppl 5:14-8.
  29. Aounallah Skhiri H, Ben Abdelkrim I, Ouldezein H, et al The cost of acute myocardial infarction management: the Tunisian experience Tunis Med. 2005 May;83 Suppl 5:24-9.
  30. Chalghoum A, Noichri Y, Chkioua L, et al Metabolic interactions between the hyperhomocysteinemia and angiotensin-1 converting enzyme activity in Tunisian patients with coronary heart disease]. Ann Biol Clin (Paris). 2012 Oct 1;70(5):599-604.
  31. Rejeb J, Omezzine A, Rebhi L et al Association of the cholesteryl ester transfer protein Taq1 B2B2 genotype with higher high-density lipoprotein cholesterol concentrations and lower risk of coronary artery disease in a Tunisian population. Arch Cardiovasc Dis. 2008 Oct;101(10):629-36.
  32. Derbali A, Mnafgui K, Affes M et al Cardioprotective effect of linseed oil against isoproterenol-induced myocardial infarction in Wistar rats: a biochemical and electrocardiographic study. J Physiol Biochem. 2015 Jun;71(2):281-8.
  33. Tourki B, Matéo P, Morand J et al Lebetin , a Snake Venom-Derived Natriuretic Peptide, Attenuates Acute Myocardial Ischemic Injury through the Modulation of Mitochondrial Permeability Transition Pore at the Time of Reperfusion. PLoS One. 2016 Sep 12;11(9):e0162632
  34. Mnafgui K, Khlif I, Hajji R et al Preventive effects of oleuropein against cardiac remodeling after myocardial infarction in Wistar rat through inhibiting angiotensin-converting enzyme activity. Toxicol Mech Methods. 2015;25(7):538-46.
  35. Mnafgui K, Hajji R, Derbali F et al Protective Effect of Hydroxytyrosol Against Cardiac Remodeling After Isoproterenol-Induced Myocardial Infarction in Rat. Cardiovasc Toxicol. 2016 Apr;16(2):147-55.
  36. Mokni M, Limam F, Elkahoui S, Amri M, Aouani E. Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. Arch Biochem Biophys. 2007 Jan 1;457(1):1-6.
  37. Bouzid K, Ben Mami Ben Miled F et al Study of cardiovascular risk factors in Tunisian patients with recent type 2 diabetes Ann Cardiol Angeiol (Paris). 2012 Apr;61(2):81-7.
  38. Lahidheb D, Mhenni H, Barakett N, Sirolimus-eluting stent in the prevention of restenosis in small coronary arteries Tunis Med. 2010 Jul;88(7):486-91.
  39. Mensah GA. Ischaemic heart disease in Africa. Heart. 2008;94:836-843.
  40. Gaziano TA, Reddy KS, Paccaud F, et al Disease Control Priorities in Developing countries. 2nd ed. New York, NY: Oxford University Press and World Bank; 2006:645-662.
  41. Prabhakaran P, Ajay VS, Prabhakaran D, Gottumukkala AK, Shrihari JS, Snehi U, Joseph B, Reddy KS. Global cardiovascular disease research survey. J Am Coll Cardiol. 2007;50:2322-2328.
  42. McKee M, Stuckler D, Basu S (2012) Where there is no health research: what can be done to fill the global gaps in health research? PLoS Med 9.
  43. Burke MA, Matlin SA, eds. Global Forum for Health Research, Monitoring Financial Flows for Health Research 2008.
  44. Sridhar D, Batniji R. Misfinancing global health: a case for transparency in disbursements and decision making. Lancet. 2008;372:1185-1191.
  45. Ghaffar A, Ijsselmuiden C, Zicker F. Changing Mindsets. Research Capacity Strengthening in Low- and Middle-Income Countries. Geneva: COHRED, Global Forum for Health Research and UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); 2008.
  46. Lozano R, Naghavi M, Foreman K, et al . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128.
  47. 36. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
  48. Baussano I, Brzoska P, Fedeli U, Larouche C, Razum O, et al. (2008) Does language matter? A case study of epidemiological and public health journals, databases and professional education in French, German and Italian. Emerg Themes Epidemiol 5: 16.
  49. Mason H, Shoaibi A, Ghandour R et al: A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries. PLoS One. 2014 Jan 7;9(1):e84445.
  50. Bonny A, Ngantcha M, Amougou SN et al Rationale and design of the Pan-African Sudden Cardiac Death survey: the Pan-African SCD study. Cardiovasc J Afr. 2014 Jul-Aug; 25(4):176-84.